Novel biological strategies to enhance the radiation therapeutic ratio
Jae Ho Kim, Kenneth A. Jenrow, Stephen L. Brown
Radiat Oncol J. 2018;36(3):172-181.   Published online 2018 Sep 30     DOI: https://doi.org/10.3857/roj.2018.00332
Citations to this article as recorded by Crossref logo
Radioprotective Potency of Nanoceria
Maryam Alvandi, Zahra Shaghaghi, Soghra Farzipour, Zeynab Marzhoseyni
Current Radiopharmaceuticals.2024; 17(2): 138.     CrossRef
Biocompatible cellulose nanocrystal-based Trojan horse enables targeted delivery of nano-Au radiosensitizers to triple negative breast cancer cells
Giacomo Biagiotti, Riccardo Cazzoli, Patrizia Andreozzi, Giusi Aresta, Mattii Francesco, Chiara Mangini, Paolo di Gianvincenzo, Chiara Tobia, Sandro Recchia, Laura Polito, Mirko Severi, Orazio Vittorio, Stefano Cicchi, Sergio E. Moya, Roberto Ronca, Adria
Nanoscale Horizons.2024; 9(7): 1211.     CrossRef
Anticancer Effects of radiation dose and dose fractionation on X-ray-induced photodynamic therapy
Ruijing Li, Peng Gao, Mengyan Dai, Fanyuan Xu, Zuhong Tian, Tianshuai Liu, Jiejing Zhou, Hongbing Lu, Junyan Rong, Wenli Zhang
Journal of Radiation Research and Applied Sciences.2024; 17(3): 100963.     CrossRef
6 MV X-band linear accelerator for stereotactic body radiation therapy
Donghyup Ha, SeungHyun Lee, Mitra Ghergherehchi, Hyojeong Choi, Ho Namgoong, Jongchul Lee, Jong-Seo Chai
Nuclear Engineering and Technology.2024;[Epub]     CrossRef
Application of nano‐radiosensitizers in combination cancer therapy
Mohammad Varzandeh, Leila Sabouri, Vahid Mansouri, Maliheh Gharibshahian, Nima Beheshtizadeh, Michael R. Hamblin, Nima Rezaei
Bioengineering & Translational Medicine.2023;[Epub]     CrossRef
Metformin and Breast Cancer: Where Are We Now?
Mónica Cejuela, Begoña Martin-Castillo, Javier A. Menendez, Sonia Pernas
International Journal of Molecular Sciences.2022; 23(5): 2705.     CrossRef
MnTnHex-2-PyP5+, Coupled to Radiation, Suppresses Metastasis of 4T1 and MDA-MB-231 Breast Cancer via AKT/Snail/EMT Pathways
Sung-Won Shin, Changhoon Choi, Hakyoung Kim, Yeeun Kim, Sohee Park, Shin-Yeong Kim, Ines Batinic-Haberle, Won Park
Antioxidants.2021; 10(11): 1769.     CrossRef
Outcomes of Radiotherapy for Mesenchymal and Non-Mesenchymal Subtypes of Gastric Cancer
Jeong Il Yu, Hee Chul Park, Jeeyun Lee, Changhoon Choi, Won Ki Kang, Se Hoon Park, Seung Tae Kim, Tae Sung Sohn, Jun Ho Lee, Ji Yeong An, Min Gew Choi, Jae Moon Bae, Kyoung-Mee Kim, Heewon Han, Kyunga Kim, Sung Kim, Do Hoon Lim
Cancers.2020; 12(4): 943.     CrossRef
Clinical Significance of Systemic Inflammation Markers in Newly Diagnosed, Previously Untreated Hepatocellular Carcinoma
Jeong Il Yu, Hee Chul Park, Gyu Sang Yoo, Seung Woon Paik, Moon Seok Choi, Hye-Seung Kim, Insuk Sohn, Heerim Nam
Cancers.2020; 12(5): 1300.     CrossRef
Identification of FES as a Novel Radiosensitizing Target in Human Cancers
Byoung Hyuck Kim, Yong Joon Kim, Myung-Ho Kim, Yi Rang Na, Daun Jung, Seung Hyeok Seok, Joon Kim, Hak Jae Kim
Clinical Cancer Research.2020; 26(1): 265.     CrossRef
Targeted Therapies and Immune-Checkpoint Inhibition in Head and Neck Squamous Cell Carcinoma: Where Do We Stand Today and Where to Go?
Jens von der Grün, Franz Rödel, Christian Brandts, Emmanouil Fokas, Matthias Guckenberger, Claus Rödel, Panagiotis Balermpas
Cancers.2019; 11(4): 472.     CrossRef
Clinical significance of radiotherapy before and/or during nivolumab treatment in hepatocellular carcinoma
Jeong Il Yu, Su Jin Lee, Jeeyun Lee, Ho Yeong Lim, Seung Woon Paik, Gyu Sang Yoo, Changhoon Choi, Hee Chul Park
Cancer Medicine.2019; 8(16): 6986.     CrossRef